Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chavez

Showing results (191-200 of 285) with videos related to

Pageof 29
Sort By:
Transplantation and Cellular Therapy|June 2, 2021
Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell LymphomaAlbert Cortes-Bullich, Ariel Perez, Christina Bachmeier, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 30, 2019
High-dose Therapy and Autologous Hematopoietic Cell Transplantation as Consolidation Treatment for Primary Effusion LymphomaAbu-Sayeef Mirza, Bhagirathbhai R Dholaria, Mohammad Hussaini, et al.
Clinical and Translational Science|October 16, 2016
Quantifying Beta-Galactosylceramide Kinetics in Cerebrospinal Fluid of Healthy Subjects Using Deuterium LabelingKms Kanhai, S C Goulooze, J Stevens, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 28, 1999
Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humansK P Vyas, R A Halpin, L A Geer, et al.
Science Translational Medicine|August 12, 2021
Engineering sperm-binding IgG antibodies for the development of an effective nonhormonal female contraceptionBhawana Shrestha, Alison Schaefer, Yong Zhu, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
Blood Neoplasia|January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasJulio C Chavez, Ellen Napier, Attilio Bondanza, et al.
Leukemia Research|June 11, 2016
Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemiaJulio C Chavez, Miguel Piris-Villaespesa, Samir Dalia, et al.
Toxicon : Official Journal of the International Society on Toxinology|February 5, 2003
Expression of a functional recombinant Phoneutria nigriventer toxin active on K+ channelsA M D Carneiro, C Kushmerick, J Koenen, et al.
Nature Reviews. Clinical Oncology|November 2, 2024
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemiaMichele D Stanchina, Skye Montoya, Alexey V Danilov, et al.
Pageof 29

Showing results (191-200 of 285) with videos related to

Sort By:
Pageof 29
Transplantation and Cellular Therapy|June 2, 2021
Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell LymphomaAlbert Cortes-Bullich, Ariel Perez, Christina Bachmeier, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 30, 2019
High-dose Therapy and Autologous Hematopoietic Cell Transplantation as Consolidation Treatment for Primary Effusion LymphomaAbu-Sayeef Mirza, Bhagirathbhai R Dholaria, Mohammad Hussaini, et al.
Clinical and Translational Science|October 16, 2016
Quantifying Beta-Galactosylceramide Kinetics in Cerebrospinal Fluid of Healthy Subjects Using Deuterium LabelingKms Kanhai, S C Goulooze, J Stevens, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 28, 1999
Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humansK P Vyas, R A Halpin, L A Geer, et al.
Science Translational Medicine|August 12, 2021
Engineering sperm-binding IgG antibodies for the development of an effective nonhormonal female contraceptionBhawana Shrestha, Alison Schaefer, Yong Zhu, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
Blood Neoplasia|January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasJulio C Chavez, Ellen Napier, Attilio Bondanza, et al.
Leukemia Research|June 11, 2016
Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemiaJulio C Chavez, Miguel Piris-Villaespesa, Samir Dalia, et al.
Toxicon : Official Journal of the International Society on Toxinology|February 5, 2003
Expression of a functional recombinant Phoneutria nigriventer toxin active on K+ channelsA M D Carneiro, C Kushmerick, J Koenen, et al.
Nature Reviews. Clinical Oncology|November 2, 2024
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemiaMichele D Stanchina, Skye Montoya, Alexey V Danilov, et al.
Pageof 29